Trial NCT01122927

View at ClinicalTrials.gov 
Org. Study IDs: 31-09-267

Last trial update was posted on 2016-02-08

MeSH Interventions

Aripiprazole

MeSH Conditions

Bipolar Disorder Mental Disorders Psychotic Disorders Schizophrenia

Other Conditions

Adolescent Schizophrenia Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features

Stopping Reasons

The trial was terminated early as the objective of the Aripiprazole Pediatric Investigational Plan was met and provided 2 years of safety data.

Limitations And Caveats

The study was terminated by the Sponsor as the European Medicines Agency P/99/2011Aripiprazole PIP which directed the sponsor to provide 2 years of safety data for at least 100 participants. The objective was met in April 2014.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID